Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Peringkat dalam Saham #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Harga Saham
$0.07600875
Terakhir disinkronkan: 2024-11-20
Kapitalisasi Pasar
$2.06M
Perubahan (1 hari)
-0.51%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Quantum Genomics S.A. (ALQGC)

Kategori

EPS untuk Quantum Genomics S.A. (ALQGC)
EPS per December 2024 TTM: $-0.26
Menurut laporan keuangan terbaru dan harga saham Quantum Genomics S.A., EPS perusahaan saat ini (TTM) adalah $-0.26. Pada akhir 2023, perusahaan memiliki EPS sebesar $-0.10 penurunan dibandingkan dengan EPS tahun 2022 sebesar $-0.77.
Riwayat EPS untuk Quantum Genomics S.A. dari 2009 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
2026 (TTM) $-0.26 85.79%
2024 $-0.14 34.49%
2023 $-0.10 -86.97%
2022 $-0.77 6.11%
2021 $-0.73 -24.35%
2020 $-0.96 71.50%
2019 $-0.56 -35.77%
2018 $-0.87 -15.36%
2017 $-1.03 55.66%
2016 $-0.66 13.06%
2015 $-0.59 5.34%
2014 $-0.56 9.39%
2013 $-0.51 1.50%
2012 $-0.50 -89.65%
2011 $-4.84 -37.57%
2010 $-7.75 -10.46%
2009 $-8.66 0.00%
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
$17.32 -6,758.98%
US
$27.74 -10,765.13%
NL
- -
CH
- -
KR
$13.70 -5,367.24%
BE